Source:http://linkedlifedata.com/resource/pubmed/id/10384156
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1999-7-15
|
pubmed:abstractText |
The aim of this study was to evaluate whether tumor cells from patients with multiple myeloma activate allogeneic and autologous T cells. Results showed that myeloma cells expressed few B7-2 and no B7-1 in six cell lines and primary cells from 11 patients. They expressed substantial levels of HLA class I, CD40, and a set of adhesion molecules. In accordance with the low density of B7 molecules on these cells, they were poor allogeneic CD8+ T cell stimulators. Neither IFN-gamma plus TNF-alpha nor CD40 stimulation significantly induced B7-1 or up-regulated B7-2 on human myeloma cell line or primary myeloma cells from six of seven patients. However, such induction was found on autologous bone-marrow nontumoral cells and on autologous dendritic cells following CD40 stimulation. High B7-1 expression was stably obtained on human myeloma cell line using transduction with a B7-1 retrovirus, enabling these cells to stimulate allogeneic CD8+, though not CD4+, T cell proliferation. For one patient with advanced disease, B7-1 gene transfer made it possible to amplify autologous cytotoxic T cells that killed autologous myeloma cells in an HLA class I-restricted manner, but not autologous PHA blasts. These results suggest that B7-1 gene transfer could be a promising immunotherapeutic approach in multiple myeloma.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD80,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Neoplasm,
http://linkedlifedata.com/resource/pubmed/chemical/Cell Adhesion Molecules,
http://linkedlifedata.com/resource/pubmed/chemical/Epitopes, T-Lymphocyte,
http://linkedlifedata.com/resource/pubmed/chemical/HLA Antigens
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0022-1767
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
163
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
514-24
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10384156-Aged,
pubmed-meshheading:10384156-Antigen-Presenting Cells,
pubmed-meshheading:10384156-Antigens, CD80,
pubmed-meshheading:10384156-Antigens, Neoplasm,
pubmed-meshheading:10384156-Cell Adhesion Molecules,
pubmed-meshheading:10384156-Cytotoxicity, Immunologic,
pubmed-meshheading:10384156-Epitopes, T-Lymphocyte,
pubmed-meshheading:10384156-Gene Transfer Techniques,
pubmed-meshheading:10384156-HLA Antigens,
pubmed-meshheading:10384156-Humans,
pubmed-meshheading:10384156-Lymphocyte Activation,
pubmed-meshheading:10384156-Lymphocyte Culture Test, Mixed,
pubmed-meshheading:10384156-Multiple Myeloma,
pubmed-meshheading:10384156-Retroviridae,
pubmed-meshheading:10384156-T-Lymphocytes, Cytotoxic,
pubmed-meshheading:10384156-Tumor Cells, Cultured
|
pubmed:year |
1999
|
pubmed:articleTitle |
Induced expression of B7-1 on myeloma cells following retroviral gene transfer results in tumor-specific recognition by cytotoxic T cells.
|
pubmed:affiliation |
Institut National de la Santé et de la Recherche Médicale Unite 475, Montpellier, France.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|